12:05 PM EDT, 09/27/2024 (MT Newswires) -- (Updates throughout with Amazon's ( AMZN ) statement.)

Amazon.com ( AMZN ) said Friday it will equip its North American operations sites with opioid overdose reversal drug naloxone.

The move makes Amazon ( AMZN ) "one of the first major companies to answer national authorities, non-profit leaders, and public health officials' calls on employers to stock the life-saving solution before an incident occurs," the company said.

Amazon ( AMZN ) said it is launching the naloxone program in two stages. It will start with Amazon's ( AMZN ) most densely populated fulfillment centers, and by early next year it will be expanded to all of its operations sites in the US.

The company will also train employees on how to identify the signs of an opioid overdose and how to administer naloxone, it said.

The Wall Street Journal first reported the news earlier Friday.

Price: 187.84, Change: -3.32, Percent Change: -1.74